Bio-Rad Laboratories Inc (BIO)
293.96
-1.77
(-0.60%)
USD |
NYSE |
May 17, 16:00
293.96
0.00 (0.00%)
After-Hours: 16:58
Bio-Rad Laboratories Market Cap: 8.385B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 8.436B |
| May 15, 2024 | 8.585B |
| May 14, 2024 | 8.387B |
| May 13, 2024 | 8.142B |
| May 10, 2024 | 8.044B |
| May 09, 2024 | 7.910B |
| May 08, 2024 | 7.652B |
| May 07, 2024 | 7.984B |
| May 06, 2024 | 8.043B |
| May 03, 2024 | 7.982B |
| May 02, 2024 | 7.967B |
| May 01, 2024 | 7.817B |
| April 30, 2024 | 7.694B |
| April 29, 2024 | 7.904B |
| April 26, 2024 | 7.871B |
| April 25, 2024 | 7.861B |
| April 24, 2024 | 7.936B |
| April 23, 2024 | 8.137B |
| April 22, 2024 | 7.990B |
| April 19, 2024 | 7.979B |
| April 18, 2024 | 8.016B |
| April 17, 2024 | 8.296B |
| April 16, 2024 | 8.350B |
| April 15, 2024 | 8.569B |
| April 12, 2024 | 8.570B |
| Date | Value |
|---|---|
| April 11, 2024 | 8.896B |
| April 10, 2024 | 9.444B |
| April 09, 2024 | 9.683B |
| April 08, 2024 | 9.308B |
| April 05, 2024 | 9.259B |
| April 04, 2024 | 9.208B |
| April 03, 2024 | 9.361B |
| April 02, 2024 | 9.376B |
| April 01, 2024 | 9.669B |
| March 28, 2024 | 9.864B |
| March 27, 2024 | 9.969B |
| March 26, 2024 | 9.711B |
| March 25, 2024 | 9.728B |
| March 22, 2024 | 9.995B |
| March 21, 2024 | 10.04B |
| March 20, 2024 | 9.590B |
| March 19, 2024 | 9.596B |
| March 18, 2024 | 9.509B |
| March 15, 2024 | 9.511B |
| March 14, 2024 | 9.480B |
| March 13, 2024 | 9.594B |
| March 12, 2024 | 9.617B |
| March 11, 2024 | 9.817B |
| March 08, 2024 | 9.803B |
| March 07, 2024 | 9.679B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
7.652B
Minimum
May 08 2024
24.59B
Maximum
Sep 02 2021
14.08B
Average
13.68B
Median
Market Cap Benchmarks
| Agilent Technologies Inc | 45.22B |
| Bruker Corp | 10.92B |
| Azenta Inc | 2.742B |
| Harvard Bioscience Inc | 146.36M |
| Bionano Genomics Inc | 75.88M |
Market Cap Related Metrics
| PS Ratio | 3.270 |
| PEG Ratio | -0.4642 |
| Price to Book Value | 0.9264 |
| Price to Free Cash Flow | 45.92 |
| Price | 293.96 |
| Earnings Yield | -3.52% |
| PEGY Ratio | -0.4642 |
| Operating PE Ratio | 26.57 |
| Normalized PE Ratio | 30.18 |